Caspofungin treatment in two infants with persistent fungaemia due to Candida lipolytica

Scandinavian Journal of Infectious Diseases

Volumn 38, Issue 6-7, 2006, Pages 559-562

  Belet, Nurşen ^a   Çiftçi, Ergin ^a   Ince, Erdal ^a   Dalgiç, Nazan ^a   Öncel, Selim ^a   Güriz, Haluk ^b   Yaǧmurlu, Aydin ^b   Dindar, Hüseyin ^b   Doǧru, Ülker ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b Section of Paediatric Surgery   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; CEFOTAXIME; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; VANCOMYCIN;

ABSENCE OF SIDE EFFECTS; ANTIBIOTIC SENSITIVITY; ARTICLE; BLOOD CULTURE; CASE REPORT; CATHETER INFECTION; CATHETER REMOVAL; CENTRAL VENOUS CATHETER; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SUBSTITUTION; FEMALE; FUNGEMIA; FUNGUS GROWTH; GASTROESOPHAGEAL REFLUX; HOSPITAL DISCHARGE; HOSPITAL INFECTION; HUMAN; INFANT; INFECTION PREVENTION; INTESTINE OBSTRUCTION; INTESTINE RESECTION; MALE; MYCOSIS; NEWBORN INFECTION; NONHUMAN; PATIENT SATISFACTION; PERSISTENT INFECTION; PNEUMONIA; POSTOPERATIVE CARE; SEPSIS; TOTAL PARENTERAL NUTRITION; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; YARROWIA LIPOLYTICA;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA; CATHETERS, INDWELLING; CROSS INFECTION; DRUG THERAPY, COMBINATION; FEMALE; FUNGEMIA; HUMANS; INFANT; INFANT, NEWBORN; MALE; PEPTIDES, CYCLIC;

EID: 33746660214     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540500404052     Document Type: Article

References (10)

1. Kullberg, BJ and Oude Lashof, AM. (2002) Epidemiology of opportunistic invasive mycoses Eur J Med Res, 7, pp. 183-91.
2. Walsh, TJ and Salkin, IF and Dixon, DM and Hurd, NJ. (1989) Clinical, microbiological, and experimental animal studies of Candida lipolytica J Clin Microbiol, 27, pp. 927-31.
3. D'Antonio, D and Romano, F and Pontieri, E and Fioritoni, G and Caracciolo, C and Bianchini, S and (2002) Catheter-related candidaemia caused by Candida lipolytica in a patient receiving allogeneic bone marrow transplantation J Clin Microbiol, 40, pp. 1381-6.
4. Shin, JH and Kook, H and Shin, DH and Hwang, TJ and Kim, M and Suh, SP and (2000) Nosocomial cluster of Candida lipolytica fungaemia in paediatric patients Eur J Clin Microbiol Infect Dis, 19, pp. 344-9.
5. Walsh, TJ and Teppler, H and Donowitz, GR and Maertens, JA and Baden, LR and Dmoszynska, A and (2004) Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia N Eng J Med, 351, pp. 1391-402.
6. Walsh, TJ. (2002) Echinocandins: An advance in the primary treatment of invasive candidiasis N Engl J Med, 347, pp. 2070-2.
7. Franklin, JA and McCormick, J and Flynn, PM. (2003) Retrospective study of the safety of caspofungin in immunocompromized paediatric patients Pediatr Infect Dis J, 22, pp. 747-9.
8. Elanjikal, Z and Sörengen, J and Schmidt, H and Dupuis, W and Tintelnot, K and Jautzke, G and (2003) Combination therapy with caspofungin and liposomal amphotericin B for invasive aspergillosis Pediatr Infect Dis J, 22, pp. 653-6.
9. Castagnola, E and Machetti, M and Cappelli, B and Molinari, AC and Morreale, G and Dodero, P and (2004) Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukaemia or undergoing allogenic bone marrow transplant Clin Microbiol Infect, 10, pp. 255-7.
10. Wertz, KK and Pretzlaff, RK. (2004) Caspofungin in paediatric patient with persistent candidaemia Pediatr Crit Care, 5, pp. 181-3.